Log in to search using one of your social media accounts:

 

Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia ® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Treats Bone Loss in Patients Using Glucocorticoid Medications who are at Increased Risk of Fracture THOUSAND OAKS, Calif., April 27, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of Prolia® (denosumab) for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture. "Today's positive opinion by the CHMP is an important step for Prolia in help...
Source: Amgen News Release - April 27, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Moberg Pharma Completes Divestment of Balmex(R) for $4.25 million
STOCKHOLM, April 27, 2018 -- (Healthcare Sales & Marketing Network) -- Moberg Pharma AB (OMX: MOB) has completed the divestment of the Balmex® brand to Randob Labs for a total consideration of $4.25 million plus the inventory value. The divestment re... Biopharmaceuticals, Acquisitions Moberg Pharma, Randob Labs, Balmex (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 27, 2018 Category: Pharmaceuticals Source Type: news

FT Health: Outfoxing the anti-vaxxers
Immunisation, ABPI’s Lisa Anson, killer stats (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 27, 2018 Category: Pharmaceuticals Source Type: news

Spermatogenesis Still Occurs in Men With Testicular Cancer
FRIDAY, April 27, 2018 -- Spermatogenesis occurs in most men with testicular cancer, often away from tumors, according to a study published online April 17 in BJU International. Jemma A. Moody, from King's College London, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

High Risk of Death After Major Diabetes-Related Amputations
FRIDAY, April 27, 2018 -- There is a high risk of postoperative mortality among patients undergoing lower-limb amputation, according to a study published online April 5 in Diabetes Care. Jason K. Gurney, Ph.D., from University of Otago in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Sickle Cell Trait Not Linked to Stroke in African-Americans
FRIDAY, April 27, 2018 -- For African-Americans, sickle cell trait (SCT) seems not to be associated with the incidence of ischemic stroke, according to a meta-analysis published online April 23 in JAMA Neurology. Hyacinth I. Hyacinth, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Knowledge Not Tied to Addictive Tanning Behavior in Millennials
FRIDAY, April 27, 2018 -- For millennials, sun protection knowledge is not associated with addictive tanning behavior, according to a recent study published in the Journal of Consumer Affairs. Amy Watson, Ph.D., from Oregon State... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Dark Chocolate Can Improve Contrast Sensitivity, Visual Acuity
FRIDAY, April 27, 2018 -- Compared with milk chocolate, consumption of dark chocolate is associated with higher contrast sensitivity and visual acuity within two hours, according to a study published online April 26 in JAMA Ophthalmology. Jeff C.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Previous Stroke Tied to Higher Risks in Aortic Valve Replacement
FRIDAY, April 27, 2018 -- For patients undergoing surgical aortic valve replacement (SAVR), previous stroke is a risk factor for recurrent ischemic stroke and major adverse cardiovascular events (MACE), according to a study published online April 25... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

ALS by Physician May Improve Traumatic Arrest Outcomes
FRIDAY, April 27, 2018 -- For patients with traumatic out-of-hospital cardiac arrest (OHCA), pre-hospital advanced life support (ALS) provided by a physician is associated with increased likelihood of one-month survival, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Potentially Inappropriate Meds Use Prevalent in Cancer Patients
FRIDAY, April 27, 2018 -- Potentially inappropriate medication (PIM) use is relatively prevalent among patients with breast or colorectal cancer, though it is not associated with most adverse outcomes, according to a study published online April 24... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Long-Acting Reversible Contraceptives Good for Teens
FRIDAY, April 27, 2018 -- Long-acting reversible contraceptives (LARC) are suitable for use by adolescents, according to a Committee Opinion published in the May issue of Obstetrics& Gynecology. Noting that from 2006 to 2010, 82 percent of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Certain Anticholinergic Drugs Appear to Raise Dementia Risk
FRIDAY, April 27, 2018 -- Use of anticholinergic drugs may be tied to a future diagnosis of dementia, according to a study published online April 25 in The BMJ. Kathryn Richardson, Ph.D., from University of East Anglia in the United Kingdom, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Walmart May Need Humana Patients To Fill Emptying Retail Space
A Humana partnership with Walmart could send millions of health plan enrollees to the retailer's stores, filling available space with healthcare services like Walgreens Boots Alliance and CVS Health are doing. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 27, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:WBA NYSE:CVS NYSE:RAD NYSE:HUM NYSE:AET Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Media News)
Source: Roche Media News - April 27, 2018 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Investor Update)
Source: Roche Investor Update - April 27, 2018 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Media News)
Source: Roche Media News - April 27, 2018 Category: Pharmaceuticals Source Type: news

A potential new weapon in the addiction battle: FDA-approved diabetes and obesity drugs
Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances. Moreover, relapse rates hover between 40 and 60 percent, similar to rates for other chronic conditions like hypertension and Type 1 diabetes. University of Pennsylvania behavioral pharmacologist and neuroscientist Heath Schmidt studies how long-term exposure to drugs such as cocaine, nicotine, and prescription opioids affects the brain and how these changes promote relapse in someone who has kicked the habit. (Source: World Pharma News)
Source: World Pharma News - April 27, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Why living in a community can be good for your health
One in three Americans is now 50 or older — by 2030, one in five will be 65+. According to the U.S. Census Bureau, the number of people age 85 and older will increase from about 14 percent of the 65+ population today, to 21 percent in 2050. Studies show that adults who live alone are more prone to social isolation and are less likely to receive help with their functional limitations. Additionally, women who live alone and are older than 85, tend to have increased risk for poor health and worse… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2018 Category: Pharmaceuticals Authors: Jay Leo Source Type: news

Sanofi misses forecasts as diabetes unit weighs on performance
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 27, 2018 Category: Pharmaceuticals Source Type: news

Oregon finds solutions for aging population with long-term care services and support
Each day, over 60,000 Oregonians receive care in their homes and in long-term care communities across the state, according to statistics compiled by the Oregon Health Care Association. That number will grow as Oregon ’s population continues to age, and Oregon’s population is aging at a record pace. According to the Oregon Office of Economic Analysis (OEA), in 2015, 645,031 Oregonians were age 65 or older, and, of that, 84,668 were 85 or older — the age group most likely to need long-term care… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2018 Category: Pharmaceuticals Authors: Oregon Health Care Association Source Type: news

Soukya: the Bangalore health retreat drawing a starry clientele — and interest from the NHS
It offers few luxuries and treatments include vomiting, yet it has become a royal favourite (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 27, 2018 Category: Pharmaceuticals Source Type: news

Bangalore’s Soukya drawing a starry clientele — and interest from the NHS
The health retreat offers few luxuries and treatments including enforced vomiting, yet has become a royal favourite (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 27, 2018 Category: Pharmaceuticals Source Type: news

Influx of federal funds could fuel region ’s R & D powerhouses
The National Institutes of Health receives a $3 billion boost for research funding after apprehension about federal cuts. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2018 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Bridgepoint explores sale of UK’s biggest NHS outsourcer
Care UK runs mobile diagnostic units, GP services, the NHS 111 line and care homes (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 27, 2018 Category: Pharmaceuticals Source Type: news

Ping An Good Doctor prices at top of range for Hong Kong IPO
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 27, 2018 Category: Pharmaceuticals Source Type: news

RURO Announces New Chief Compliance Officer
RURO announced today that Stephen Ferrell CISA CRISC, formerly Vice President of Product Strategy at ByteGrid, will join RURO as its Chief Compliance Officer.(PRWeb April 27, 2018)Read the full story at http://www.prweb.com/releases/2018/04/prweb15447893.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 27, 2018 Category: Pharmaceuticals Source Type: news

Novel Assay Monitors Kinetics of Cell Migration in High Throughput...
While new AccuWound tool generates 96 identical scratch wounds in just seconds, wound healing is subsequently monitored in real-time by xCELLigence instrument, yielding cell migration kinetics with...(PRWeb April 27, 2018)Read the full story at http://www.prweb.com/releases/2018/04/prweb15447572.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 27, 2018 Category: Pharmaceuticals Source Type: news

1-800-PetMeds ® Sends Pasco County ’s Favorite K-9 Heroes an...
As a thank you for helping keep 1-800-PetMeds® home state of Florida safe, America’s Largest Pet Pharmacy® has filled boxes of goodies for the hardworking pups of the Pasco Sheriff’s Office.(PRWeb April 27, 2018)Read the full story at http://www.prweb.com/releases/2018/04/prweb15445787.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 27, 2018 Category: Pharmaceuticals Source Type: news

Kansas City University College of Medicine Faculty Encourage...
The opioid crisis in the United States has underscored the problem of patients and family members storing unused medications, especially pain medications, long after they were prescribed or needed....(PRWeb April 27, 2018)Read the full story at http://www.prweb.com/releases/2018/04/prweb15447955.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 27, 2018 Category: Pharmaceuticals Source Type: news

Vertex Pharma profit tops estimates on strong launch of new CF drug
(Reuters) - Vertex Pharmaceuticals Inc topped analysts' forecasts for quarterly profit on Thursday, led by stronger-than expected sales of its latest cystic fibrosis drug as well as double-digit growth in sales of older treatments. (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

26.04.18: Issues raised by regulatory authorities in respect of Monsanto acquisition addressed:
Bayer signs agreement to sell further Crop Science businesses to BASF for up to 1.7 billion eurosPackage includes global vegetable seeds business, certain seed treatments and digital farming activities / Businesses generated total sales of 745 million euros in 2017 / Sale is subject to successful closing of Monsanto acquisitionmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 26, 2018 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Announces Dividend Increase of 7.1%
(Source: Johnson and Johnson)
Source: Johnson and Johnson - April 26, 2018 Category: Pharmaceuticals Source Type: news

A Worrying Number Of People Believe In Fake Causes Of Cancer
A worrying number of people believe in fake causes of cancer with no scientific evidence to back up their beliefs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 26, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

A Worrying Number Of People Believe In Fake Causes Of Cancer, Study Shows
A worrying number of people believe in fake causes of cancer with no scientific evidence to back up their beliefs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 26, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Northwest Kidney Centers preps for big expansion, including $43M Burien campus
Northwest Kidney Centers is adding more dialysis centers in South King County and a $43 million on a Burien campus. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Coral Garnick Source Type: news

Veteran cancer researcher takes over management of UC Davis center
As the new director of the UC Davis Comprehensive Cancer Center, Dr. Primo Lara hopes to secure funding to support innovate cancer research and treatments. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Kayla Webster Source Type: news

New CareSource building to honor company founder
The new CareSource building in downtown Dayton will honor the company's founder when it its completed next year. The facility, which was previously known as CareSource Center City, will be named the Pamela Morris Center. Morris, who is retiring in May, launched the health insurance company in 1989 and has served as its CEO ever since. Under her leadership, CareSource has become one of the largest employers i n the Dayton region and one of the fastest-growing companies. “As founder of CareSource… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: John Bush Source Type: news

Blue Cross promotes two company veterans
Blue Cross and Blue Shield of Alabama has promoted two company veterans. Dr. Dow Briggs has been named executive vice president. Briggs most recently served as chief business officer, with responsibility for all aspects of claims, customer services, sales and marketing, health care networks and health management.  Briggs has been with Blue Cross since 2004 and has s erved as associate medical director, medical director, vice president of health management and senior vice president of business… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

ECMC, Oishei Children's verified for Level 1 trauma treatment
Following reviews by the American College of Surgeons, two Buffalo hospitals have again received verification as Level 1 trauma centers. Both Erie County Medical Center and Kaleida Health's John R. Oishei Children's Hospital were reviewed by the organization's verification review committee, which oversees the ability to provide care for injured patients. They are also the only two hospitals designated at Level 1 for trauma by the s tate Department of Health for the Western New York region. A Level… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Newsmaker: Children's Mercy doc sees genomics easing suffering, families' anxiety
Dr. Tomi Pastinen leads the Center for Pediatric Genomic Medicine for Children's Mercy. The self-described "science geek" sees very practical applications for his research work. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Juno CEO quietly steps down after $9 billion Celgene acquisition
Hans Bishop said Tuesday that he recently left the CEO role and joined Celgene's board of directors. Bishop had led Juno since it spun out of the Fred Hutchinson Cancer Research Center in 2013. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Casey Coombs Source Type: news

One Community: Columbus Health Commissioner Mysheika Roberts seeks public private partners to help treat health inequities
Columbus Health Commissioner Dr. Mysheika Roberts can ’t build an affordable apartment complex or open a grocery store in Linden, but she’s looking for public and private partners who can. Roberts was promoted to the top job at Columbus Public Health in January after several years as deputy commissioner and medical director. Serving many of the ci ty’s lowest-income residents, the agency seeks long-term solutions to sharp inequities that are collectively called social determinants of health:… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

One Community: Health experts prescribe safe, affordable housing
In Franklin County, black infants are twice as likely as white infants to die before their first birthday – the most stark of several health inequities across race, income and sexual identity. The county’s overall infant mortality rate changed little from 2000 to 2015. Many of the contributing risks – poor prenatal care, nutrition, lead contamination, chronic stress among them – can be traced ba ck to unsafe and unstable housing. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

PRA ’s longtime CFO to retire
Longtime PRA Health Sciences (Nasdaq: PRAH) Chief Financial Officer Linda Baddour is retiring as the Raleigh-based contract research organization sees a strong start to 2018. While she her retirement as CFO takes effect May 1, PRA said she will remain executive vice president through Sept. 30 to assist with the transition and serve as a special advisor to Chairman and CEO Colin Shannon. Michael Bonello – who joined PRA back in 2008 and currently serves as senior vic e president of accounting and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2018 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Hemoglobin A1c Levels Not Tied to Wound Outcomes
THURSDAY, April 26, 2018 -- There does not appear to be a clinically meaningful association between baseline or prospective hemoglobin A1c (A1C) and wound healing in patients with diabetic foot ulcers (DFUs), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2018 Category: Pharmaceuticals Source Type: news

Drug-Related Endocarditis Cases Up From 2007 to 2015
THURSDAY, April 26, 2018 -- Over the last nine years, there was an increase in the number of endocarditis cases, which mirrored the increase in concomitant use of mixed drugs, according to a study presented at the annual meeting of the Society for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2018 Category: Pharmaceuticals Source Type: news

Inadequate Functional Health Literacy Mars Post-Op Recovery
THURSDAY, April 26, 2018 -- For patients undergoing day surgery, inadequate functional health literacy (FHL) is associated with poorer postoperative recovery and lower health-related quality of life, according to a study published online April 25 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2018 Category: Pharmaceuticals Source Type: news

Improvement in Race-Based Disparities in Years of Life Lost
THURSDAY, April 26, 2018 -- From 1990 to 2014 there was a decrease in race-based disparities in years of life lost (YLL) in the United States, according to a study published online April 25 in PLOS ONE. Jeanine M. Buchanich, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2018 Category: Pharmaceuticals Source Type: news

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers
THURSDAY, April 26, 2018 -- Very low doses of hyaluronidase can remove hyaluronic acid filler nodules, but more rapid resolution is seen with slightly higher doses, according to a study published online April 25 in JAMA Dermatology. Murad Alam,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2018 Category: Pharmaceuticals Source Type: news